Safety and Benefit Study of Droxidopa to Treat Patients With Intradialytic Hypotension
Condition(s):Intradialytic HypotensionLast Updated:June 27, 2014Completed
Hide Studies Not Open or Pending
Condition(s):Intradialytic HypotensionLast Updated:June 27, 2014Completed
Condition(s):Symptomatic Neurogenic Orthostatic Hypotension (NOH); Non-diabetic Neuropathy; Primary Autonomic Failure; Dopamine Beta Hydroxylase DeficiencyLast Updated:May 20, 2014Completed
Condition(s):Shy-Drager Syndrome; Orthostatic HypotensionLast Updated:September 18, 2008Completed
Condition(s):Impulse Control DisorderLast Updated:March 10, 2021Completed
Condition(s):Parkinson Disease; Virtual Reality Therapy; Functional Magnetic Resonance ImagingLast Updated:October 19, 2021Terminated
Condition(s):Parkinson DiseaseLast Updated:August 23, 2023Recruiting
Condition(s):Parkinson Disease; Cognitive ImpairmentLast Updated:July 24, 2023Recruiting
Condition(s):Parkinson’s Disease; Mpulse Control DisordersLast Updated:January 19, 2022Completed
Condition(s):Idiopathic Parkinson’s DiseaseLast Updated:September 9, 2015Completed
Condition(s):Parkinson DiseaseLast Updated:October 15, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.